Request More Information

Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Experts Commenting on This Company


Visit Company Website

View Company News

MiMedx Group Inc.


MiMedx Group Inc. is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its mission is to give physicians products and tissues to help the body heal itself. The company's biomaterial platform technologies include AmnioFix and EpiFix, tissue technologies processed from human amniotic membrane that is derived from donated placentas. MiMedx processes the human amniotic membrane with its proprietary Purion process to produce a safe and effective implant. MiMedx is the leading supplier of amniotic tissue, having supplied over 250,000 allografts to date for application in the wound care, surgical, sports medicine, ophthalmic and dental sectors of healthcare.

The information provided below is from analysts, newsletters and other contributors. Please contact the company and visit its website before making an investment decision.

Expert Comments:

William Plovanic, Canaccord Genuity (8/19/14) "In the wound care space, my favorite company is MiMedx Group Inc., which is providing better, faster and cheaper technology compared to current therapies. . .MiMedx is focused on advanced wound-covering/regeneration technologies in the skin substitute market. MiMedx uses amniotic tissue derived from live birth placenta. Published clinical data demonstrated a 92% wound-healing rate in diabetic foot ulcers. Patients typically require two or three grafts, with a total cost per patient of $2-3K.

Since commercializing its products over the last several years, MiMedx has grown significantly and has taken a significant portion of market share. The products work well, reimbursement is in place and distribution continues to ramp to properly address the U.S. market." More >

Due to permission requirements, not all quotes are shown.

MiMedx Group Inc. Content

Back to Top